Literature DB >> 31757951

Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2.

Rick A C M Boonen1, Amélie Rodrigue2,3, Chantal Stoepker1, Wouter W Wiegant1, Bas Vroling4, Milan Sharma1, Magdalena B Rother1, Nandi Celosse1, Maaike P G Vreeswijk1, Fergus Couch5, Jacques Simard2,6, Peter Devilee1,7, Jean-Yves Masson2,3, Haico van Attikum8.   

Abstract

Heterozygous carriers of germ-line loss-of-function variants in the DNA repair gene PALB2 are at a highly increased lifetime risk for developing breast cancer. While truncating variants in PALB2 are known to increase cancer risk, the interpretation of missense variants of uncertain significance (VUS) is in its infancy. Here we describe the development of a relatively fast and easy cDNA-based system for the semi high-throughput functional analysis of 48 VUS in human PALB2. By assessing the ability of PALB2 VUS to rescue the DNA repair and checkpoint defects in Palb2 knockout mouse embryonic stem (mES) cells, we identify various VUS in PALB2 that impair its function. Three VUS in the coiled-coil domain of PALB2 abrogate the interaction with BRCA1, whereas several VUS in the WD40 domain dramatically reduce protein stability. Thus, our functional assays identify damaging VUS in PALB2 that may increase cancer risk.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31757951      PMCID: PMC6876638          DOI: 10.1038/s41467-019-13194-2

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  54 in total

1.  Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

Authors:  Bing Xia; Josephine C Dorsman; Najim Ameziane; Yne de Vries; Martin A Rooimans; Qing Sheng; Gerard Pals; Abdellatif Errami; Eliane Gluckman; Julian Llera; Weidong Wang; David M Livingston; Hans Joenje; Johan P de Winter
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

2.  REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants.

Authors:  Nilah M Ioannidis; Joseph H Rothstein; Vikas Pejaver; Sumit Middha; Shannon K McDonnell; Saurabh Baheti; Anthony Musolf; Qing Li; Emily Holzinger; Danielle Karyadi; Lisa A Cannon-Albright; Craig C Teerlink; Janet L Stanford; William B Isaacs; Jianfeng Xu; Kathleen A Cooney; Ethan M Lange; Johanna Schleutker; John D Carpten; Isaac J Powell; Olivier Cussenot; Geraldine Cancel-Tassin; Graham G Giles; Robert J MacInnis; Christiane Maier; Chih-Lin Hsieh; Fredrik Wiklund; William J Catalona; William D Foulkes; Diptasri Mandal; Rosalind A Eeles; Zsofia Kote-Jarai; Carlos D Bustamante; Daniel J Schaid; Trevor Hastie; Elaine A Ostrander; Joan E Bailey-Wilson; Predrag Radivojac; Stephen N Thibodeau; Alice S Whittemore; Weiva Sieh
Journal:  Am J Hum Genet       Date:  2016-09-22       Impact factor: 11.025

Review 3.  The Tumor Suppressor PALB2: Inside Out.

Authors:  Mandy Ducy; Laura Sesma-Sanz; Laure Guitton-Sert; Anahita Lashgari; Yuandi Gao; Nadine Brahiti; Amélie Rodrigue; Guillaume Margaillan; Marie-Christine Caron; Jacques Côté; Jacques Simard; Jean-Yves Masson
Journal:  Trends Biochem Sci       Date:  2019-01-10       Impact factor: 13.807

4.  Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations.

Authors:  Suhwan Chang; Kajal Biswas; Betty K Martin; Stacey Stauffer; Shyam K Sharan
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

5.  Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.

Authors:  Cornelia Kraus; Juliane Hoyer; Georgia Vasileiou; Marius Wunderle; Michael P Lux; Peter A Fasching; Mandy Krumbiegel; Steffen Uebe; Miriam Reuter; Matthias W Beckmann; André Reis
Journal:  Int J Cancer       Date:  2016-09-23       Impact factor: 7.396

6.  BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.

Authors:  Hermela Shimelis; Romy L S Mesman; Catharina Von Nicolai; Asa Ehlen; Lucia Guidugli; Charlotte Martin; Fabienne M G R Calléja; Huong Meeks; Emily Hallberg; Jamie Hinton; Jenna Lilyquist; Chunling Hu; Cora M Aalfs; Kristiina Aittomäki; Irene Andrulis; Hoda Anton-Culver; Volker Arndt; Matthias W Beckmann; Javier Benitez; Natalia V Bogdanova; Stig E Bojesen; Manjeet K Bolla; Anne-Lise Borresen-Dale; Hiltrud Brauch; Paul Brennan; Hermann Brenner; Annegien Broeks; Barbara Brouwers; Thomas Brüning; Barbara Burwinkel; Jenny Chang-Claude; Georgia Chenevix-Trench; Ching-Yu Cheng; Ji-Yeob Choi; J Margriet Collée; Angela Cox; Simon S Cross; Kamila Czene; Hatef Darabi; Joe Dennis; Thilo Dörk; Isabel Dos-Santos-Silva; Alison M Dunning; Peter A Fasching; Jonine Figueroa; Henrik Flyger; Montserrat García-Closas; Graham G Giles; Gord Glendon; Pascal Guénel; Christopher A Haiman; Per Hall; Ute Hamann; Mikael Hartman; Frans B Hogervorst; Antoinette Hollestelle; John L Hopper; Hidemi Ito; Anna Jakubowska; Daehee Kang; Veli-Matti Kosma; Vessela Kristensen; Kah-Nyin Lai; Diether Lambrechts; Loic Le Marchand; Jingmei Li; Annika Lindblom; Artitaya Lophatananon; Jan Lubinski; Eva Machackova; Arto Mannermaa; Sara Margolin; Frederik Marme; Keitaro Matsuo; Hui Miao; Kyriaki Michailidou; Roger L Milne; Kenneth Muir; Susan L Neuhausen; Heli Nevanlinna; Janet E Olson; Curtis Olswold; Jan J C Oosterwijk; Ana Osorio; Paolo Peterlongo; Julian Peto; Paul D P Pharoah; Katri Pylkäs; Paolo Radice; Muhammad Usman Rashid; Valerie Rhenius; Anja Rudolph; Suleeporn Sangrajrang; Elinor J Sawyer; Marjanka K Schmidt; Minouk J Schoemaker; Caroline Seynaeve; Mitul Shah; Chen-Yang Shen; Martha Shrubsole; Xiao-Ou Shu; Susan Slager; Melissa C Southey; Daniel O Stram; Anthony Swerdlow; Soo H Teo; Ian Tomlinson; Diana Torres; Thérèse Truong; Christi J van Asperen; Lizet E van der Kolk; Qin Wang; Robert Winqvist; Anna H Wu; Jyh-Cherng Yu; Wei Zheng; Ying Zheng; Jennifer Leary; Logan Walker; Lenka Foretova; Florentia Fostira; Kathleen B M Claes; Liliana Varesco; Setareh Moghadasi; Douglas F Easton; Amanda Spurdle; Peter Devilee; Harry Vrieling; Alvaro N A Monteiro; David E Goldgar; Aura Carreira; Maaike P G Vreeswijk; Fergus J Couch
Journal:  Cancer Res       Date:  2017-03-10       Impact factor: 12.701

7.  The functional impact of variants of uncertain significance in BRCA2.

Authors:  Romy L S Mesman; Fabienne M G R Calléja; Giel Hendriks; Bruno Morolli; Branislav Misovic; Peter Devilee; Christi J van Asperen; Harry Vrieling; Maaike P G Vreeswijk
Journal:  Genet Med       Date:  2018-07-10       Impact factor: 8.822

8.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.

Authors:  Hannah Farmer; Nuala McCabe; Christopher J Lord; Andrew N J Tutt; Damian A Johnson; Tobias B Richardson; Manuela Santarosa; Krystyna J Dillon; Ian Hickson; Charlotte Knights; Niall M B Martin; Stephen P Jackson; Graeme C M Smith; Alan Ashworth
Journal:  Nature       Date:  2005-04-14       Impact factor: 69.504

9.  PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response.

Authors:  Srilatha Simhadri; Gabriele Vincelli; Yanying Huo; Sarah Misenko; Tzeh Keong Foo; Johanna Ahlskog; Claus S Sørensen; Gregory G Oakley; Shridar Ganesan; Samuel F Bunting; Bing Xia
Journal:  Oncogene       Date:  2018-10-18       Impact factor: 9.867

10.  CADD: predicting the deleteriousness of variants throughout the human genome.

Authors:  Philipp Rentzsch; Daniela Witten; Gregory M Cooper; Jay Shendure; Martin Kircher
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

View more
  17 in total

Review 1.  BRCA1-Dependent and Independent Recruitment of PALB2-BRCA2-RAD51 in the DNA Damage Response and Cancer.

Authors:  Tzeh Keong Foo; Bing Xia
Journal:  Cancer Res       Date:  2022-09-16       Impact factor: 13.312

Review 2.  Hypothesis: Why Different Types of SDH Gene Variants Cause Divergent Tumor Phenotypes.

Authors:  Jean-Pierre Bayley; Peter Devilee
Journal:  Genes (Basel)       Date:  2022-06-07       Impact factor: 4.141

3.  The importance of DNAPKcs for blunt DNA end joining is magnified when XLF is weakened.

Authors:  Metztli Cisneros-Aguirre; Felicia Wednesday Lopezcolorado; Linda Jillianne Tsai; Ragini Bhargava; Jeremy M Stark
Journal:  Nat Commun       Date:  2022-06-27       Impact factor: 17.694

4.  The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise the DNA damage response.

Authors:  Yue Zhang; Jung-Young Park; Fan Zhang; Sara H Olson; Irene Orlow; Yirong Li; Robert C Kurtz; Marc Ladanyi; Jie Chen; Amanda E Toland; Liying Zhang; Paul R Andreassen
Journal:  Hum Mutat       Date:  2020-12-16       Impact factor: 4.878

5.  Functional interrogation of DNA damage response variants with base editing screens.

Authors:  Raquel Cuella-Martin; Samuel B Hayward; Xiao Fan; Xiao Chen; Jen-Wei Huang; Angelo Taglialatela; Giuseppe Leuzzi; Junfei Zhao; Raul Rabadan; Chao Lu; Yufeng Shen; Alberto Ciccia
Journal:  Cell       Date:  2021-02-18       Impact factor: 41.582

6.  Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Marc Tischkowitz; Judith Balmaña; William D Foulkes; Paul James; Joanne Ngeow; Rita Schmutzler; Nicoleta Voian; Myra J Wick; Douglas R Stewart; Tuya Pal
Journal:  Genet Med       Date:  2021-05-11       Impact factor: 8.864

7.  A Validated Functional Analysis of Partner and Localizer of BRCA2 Missense Variants for Use in Clinical Variant Interpretation.

Authors:  Sarah E Brnich; Eyla Cristina Arteaga; Yueting Wang; Xianming Tan; Jonathan S Berg
Journal:  J Mol Diagn       Date:  2021-05-06       Impact factor: 5.341

8.  Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway.

Authors:  Antonella Padella; Maria Chiara Fontana; Giovanni Marconi; Eugenio Fonzi; Elisabetta Petracci; Anna Ferrari; Carmen Baldazzi; Cristina Papayannidis; Andrea Ghelli Luserna Di Rorá; Nicoletta Testoni; Gastone Castellani; Torsten Haferlach; Giovanni Martinelli; Giorgia Simonetti
Journal:  Blood Cancer J       Date:  2021-01-07       Impact factor: 11.037

Review 9.  Functional Characterization of PALB2 Variants of Uncertain Significance: Toward Cancer Risk and Therapy Response Prediction.

Authors:  Rick A C M Boonen; Maaike P G Vreeswijk; Haico van Attikum
Journal:  Front Mol Biosci       Date:  2020-09-16

Review 10.  Personalized early detection and prevention of breast cancer: ENVISION consensus statement.

Authors:  Nora Pashayan; Antonis C Antoniou; Urska Ivanus; Laura J Esserman; Douglas F Easton; David French; Gaby Sroczynski; Per Hall; Jack Cuzick; D Gareth Evans; Jacques Simard; Montserrat Garcia-Closas; Rita Schmutzler; Odette Wegwarth; Paul Pharoah; Sowmiya Moorthie; Sandrine De Montgolfier; Camille Baron; Zdenko Herceg; Clare Turnbull; Corinne Balleyguier; Paolo Giorgi Rossi; Jelle Wesseling; David Ritchie; Marc Tischkowitz; Mireille Broeders; Dan Reisel; Andres Metspalu; Thomas Callender; Harry de Koning; Peter Devilee; Suzette Delaloge; Marjanka K Schmidt; Martin Widschwendter
Journal:  Nat Rev Clin Oncol       Date:  2020-06-18       Impact factor: 65.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.